相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Hans-Willi Mittrucker et al.
JOURNAL OF IMMUNOLOGY (2017)
Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral IRF3 Modulates Major Histocompatibility Complex Class II (MHC-II) Antigen Presentation through MHC-II Transactivator-Dependent and -Independent Mechanisms: Implications for Oncogenesis
Jianmin Zuo et al.
JOURNAL OF VIROLOGY (2013)
T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells
Shereen Sabbah et al.
BLOOD (2012)
Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression and Function of Endothelial Cell Major Histocompatibility Complex Class II via Suppressor of Cytokine Signaling 3
L. M. Butler et al.
JOURNAL OF VIROLOGY (2012)
Kaposi's Sarcoma Herpesvirus Upregulates Aurora A Expression to Promote p53 Phosphorylation and Ubiquitylation
Qiliang Cai et al.
PLOS PATHOGENS (2012)
The RBP-Jκ Binding Sites within the RTA Promoter Regulate KSHV Latent Infection and Cell Proliferation
Jie Lu et al.
PLOS PATHOGENS (2012)
IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion
Donatella Aldinucci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Regulation of major histocompatibility complex class II genes
Nancy M. Choi et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
The Single RBP-Jκ Site within the LANA Promoter Is Crucial for Establishing Kaposi's Sarcoma-Associated Herpesvirus Latency during Primary Infection
Jie Lu et al.
JOURNAL OF VIROLOGY (2011)
Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 3 Inhibits Gamma Interferon and Major Histocompatibility Complex Class II Expression
Katharina Schmidt et al.
JOURNAL OF VIROLOGY (2011)
The Internal Kaposi's Sarcoma-Associated Herpesvirus LANA Regions Exert a Critical Role on Episome Persistence
Erika De Leon Vazquez et al.
JOURNAL OF VIROLOGY (2011)
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Christian Steidl et al.
NATURE (2011)
The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation
Hyun Jin Kwun et al.
VIROLOGY (2011)
Epstein-Barr Virus Nuclear Antigen 3C Stabilizes Gemin3 to Block p53-mediated Apoptosis
Qiliang Cai et al.
PLOS PATHOGENS (2011)
Interferon Regulatory Factor 4: Combinational Control of Lymphocyte Differentiation
Marc Veldhoen
IMMUNITY (2010)
Kaposi's Sarcoma-Associated Herpesvirus Inhibits Interleukin-4-Mediated STAT6 Phosphorylation To Regulate Apoptosis and Maintain Latency
Qiliang Cai et al.
JOURNAL OF VIROLOGY (2010)
The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5
Effi Wies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Upregulates Survivin Expression in KSHV-Associated B-Lymphoma Cells and Contributes to Their Proliferation
Jie Lu et al.
JOURNAL OF VIROLOGY (2009)
IRF-4 functions as a tumor suppressor in early B-cell development
Jaime Acquaviva et al.
BLOOD (2008)
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes
Dongsheng Xu et al.
JOURNAL OF VIROLOGY (2008)
IRF4 addiction in multiple myeloma
Arthur L. Shaffer et al.
NATURE (2008)
Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA
Rajeev Kaul et al.
VIROLOGY (2007)
MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-γ
Mojun Zhao et al.
MOLECULAR IMMUNOLOGY (2007)
Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells
Dimitrios Lagos et al.
BLOOD (2007)
In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma Herpes virus
Arnaud Zaldumbide et al.
MOLECULAR IMMUNOLOGY (2007)
IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features
L. Gabriele et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors
Qi-Liang Cai et al.
PLOS PATHOGENS (2006)
Expression of Kaposi's sarcoma-associated herpesvirus-encoded K10/10.1 protein in tissues and its interaction with poly(A)-binding protein
Takayuki Kanno et al.
VIROLOGY (2006)
Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1α to upregulate RTA expression during hypoxia:: Latency control under low oxygen conditions
Qiliang Cai et al.
JOURNAL OF VIROLOGY (2006)
Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome
Andrew J. Barbera et al.
CELL CYCLE (2006)
Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-γ
JF Piskurich et al.
MOLECULAR IMMUNOLOGY (2006)
Negative regulation of Toll-like-receptor signaling by IRF-4
H Negishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
IRF-4 expression in the human myeloid lineage:: up-regulation during dendritic cell differentiation and inhibition by 1α,25-dihydroxyvitamin D3
MC Gauzzi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines
HM Long et al.
JOURNAL OF VIROLOGY (2005)
E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII)
N van der Stoep et al.
BLOOD (2004)
Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines
M Arguello et al.
ONCOGENE (2003)
Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1
H Shinohara et al.
JOURNAL OF VIROLOGY (2002)
Repression of IRF-4 target genes in human T cell leukemia virus-1 infection
Y Mamane et al.
ONCOGENE (2002)
Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene
JM Waldburger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity
C Lim et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis
L Coscoy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases - Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
C Parravicini et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors
B Lubyova et al.
JOURNAL OF VIROLOGY (2000)
分享论文
